Lenalidomide for the asheville VAMC for patient care.
Active Awarded Last action
- Contract number
- 36C24626N0413
- Awardee
-
Exelan Pharmaceuticals Inc. UEI FYZXNHSQTMG8
- Awarding agency
-
Veterans Integrated Service Network 6
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $3,014,589
Award facts
- Contract value 100% obligated
- $3,014,589.14 Current and potential, with all options
- Completion date 76% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Boca Raton, FL 33432, USA
Award details come from SAM.gov/FPDS.
About this award
Exelan Pharmaceuticals Inc., a Boca Raton, Florida-based pharmaceutical manufacturing and distribution company, was awarded a $3.01 million delivery order by Veterans Integrated Service Network 6 on January 15, 2026, for the supply of Lenalidomide to the Asheville Veterans Affairs Medical Center. This firm-fixed-price delivery order, with an ultimate completion date of January 14, 2027, is issued under the parent Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and does not include a set-aside designation, allowing unrestricted competition. The contract supports the VA's oncology and hematologic malignancy treatment protocols by providing critical pharmaceutical products to veteran patients requiring cancer care.
Exelan Pharmaceuticals operates as a prime contractor with no identified major subcontractors and performs substantially all work at its Boca Raton facility or designated delivery locations. The company maintains an extensive portfolio of Indefinite Delivery Contracts with the VA National Acquisition Center and Defense Logistics Agency, with individual IDC ceiling values ranging from $12.8 million to $88.2 million for various pharmaceutical products. This delivery order represents a continuation of Exelan's established role as a long-term strategic supplier to the federal healthcare system, with previous Lenalidomide delivery orders to multiple Veterans Integrated Service Networks ranging from approximately $6,500 to $4.77 million.
Quick answers
Who was awarded contract 36C24626N0413?
36C24626N0413 was awarded to Exelan Pharmaceuticals Inc. by Veterans Integrated Service Network 6 (Veterans Health Administration) on January 15, 2026.
How much is contract 36C24626N0413 worth?
The government has obligated $3,014,589 on 36C24626N0413.
Is contract 36C24626N0413 an order under another contract?
Yes. 36C24626N0413 is a delivery order under 36F79720D0227, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24626N0413 competed?
The extent of competition for 36C24626N0413 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award